accreditation
What Accreditation or Certification Claims Mean on a Tesamorelin Listing
A guide to reading accreditation and certification claims on tesamorelin listings, including what a COA verifies, what facility badges cover, and what they don't.
Medically reviewed by Catherine Dumont, MD, physician and clinical researcher — Last reviewed
Catherine Dumont, MD is a physician with clinical and research training in endocrinology and growth hormone therapeutics, with post-graduate research in GHRH analog applications and growth hormone axis disorders.
Accreditation or certification claims on a tesamorelin listing usually point to one of three things: a certificate of analysis for that specific batch, a facility-level quality designation like ISO or GMP, or a general “third-party tested” statement with no attached document. These terms are not interchangeable, and a listing that leans on one to imply the others is worth a closer look. Understanding what each claim actually verifies — and what it leaves unverified — is the fastest way to separate a documented listing from one that only sounds documented.
Certificate of Analysis: What It Covers
A certificate of analysis (COA) is a lab report tied to one specific manufacturing lot. It typically states the peptide’s identity (confirmed by mass spectrometry or a comparable method), a purity percentage (usually from high-performance liquid chromatography, or HPLC), the net peptide content, and sometimes residual solvent or moisture figures. A COA is only meaningful when it is legible, dated, and tied to a lot number that matches the vial in hand. A COA with no lot number, no testing method listed, or a date that predates the batch it supposedly covers does not function as documentation — it functions as a picture of a document.
This is the core meaning of “certification” in the context of a tesamorelin listing: certification of a batch, not certification of the seller, the brand, or the product line as a whole. A supplier can hold a strong COA for one lot and a weak or absent one for the next. Listings that display a single “representative” COA across every batch are describing a policy, not a result.
Third-Party Testing vs. Self-Reported Testing
“Third-party tested” means an independent laboratory, with no ownership stake in the supplier, ran the analysis. This distinction matters because self-reported purity figures — numbers a supplier states without an attached lab document — carry no independent verification. A listing that says “third-party tested” but does not name the lab, does not link a report, or shows a report with the lab’s identifying information cropped out is making a claim that cannot be checked. The detection methods used to confirm growth hormone-releasing hormone (GHRH) analogs like tesamorelin, including chromatographic and mass spectrometry techniques, are well established in the analytical literature, which means a legitimate lab report should reference a recognizable method rather than a vague “purity confirmed” statement (as discussed in a 2021 review of detection methods for synthetic GHRH analogs).
A useful check: search for the named lab independently. Laboratories that do this kind of analytical chemistry work generally have a public presence, a method list, and a way to verify that a report number belongs to them. A lab name that returns no independent trace is a signal to treat the report with caution.
Facility Accreditation: ISO, GMP, and What They Actually Certify
ISO certification and GMP (Good Manufacturing Practice) claims describe how a facility operates — its quality management systems, documentation practices, and process controls — not the chemical content of a specific vial. A facility can be ISO-certified for its quality management system and still ship a lot that fails a purity check, because facility accreditation is an audit of process, conducted periodically, while a COA is a test of product, conducted per batch. Conflating the two is one of the more common ways a listing sounds more rigorous than the documentation behind it actually supports.
Research-grade GHRH analog manufacturing that has appeared in published clinical work, including tesamorelin trials in HIV-associated lipodystrophy, relied on materials with defined manufacturing and analytical controls appropriate to a clinical research setting (as reflected in the methods sections of published Phase III safety data on tesamorelin’s side-effect profile and in 52-week safety and efficacy findings). That standard of material control is a useful reference point: it illustrates what “characterized” actually looks like in practice — named methods, defined acceptance criteria, and batch-level records — rather than a badge graphic with no supporting document.
Reading a COA Line by Line
A usable COA generally includes the following fields. The table below separates what each field verifies from what it does not.
| COA Field | What It Verifies | What It Does Not Verify |
|---|---|---|
| Lot/batch number | Which production run the report covers | Whether the vial received matches that lot |
| Identity test (e.g., mass spec) | The molecule matches the expected sequence | Purity or concentration |
| Purity percentage (HPLC) | Proportion of the sample matching the target peptide | Sterility or endotoxin status |
| Net peptide content | Actual peptide mass versus salt/buffer content | Storage or shipping conditions after testing |
| Testing lab name/accreditation | Whether an independent party ran the test | Whether the report is unaltered |
| Report date | When the sample was tested | Whether the vial was tested before or after this date |
None of these fields, alone or together, confirms that the vial a buyer receives is the one the report describes. That link — matching a physical vial to a specific COA — depends on the lot number being both present and legible on the vial label, which is a detail worth checking directly against the listing.
Why Purity Percentage Changes the Actual Content
A purity claim is not cosmetic; it changes the usable mass in a vial. If a listing states a vial contains 10 mg of tesamorelin at 98% purity, the peptide fraction of that vial is 10 mg × 0.98 = 9.8 mg, with the remaining 0.2 mg made up of non-peptide material such as residual salts, counter-ions, or synthesis byproducts. Recomputed the same way: 10 × 0.98 = 9.8, confirming the figure. A drop from 98% to 90% purity on the same nominal 10 mg vial changes the peptide content to 10 mg × 0.90 = 9.0 mg, a 0.8 mg difference that a purity number alone communicates but a vague “high purity” label does not. This is why a specific percentage tied to a named method carries more information than an adjective, and why a COA that omits the percentage entirely is missing the one figure that matters most for characterizing the batch. Researchers working through reconstitution or concentration math after purity is established may find a dedicated calculator, such as the one at peptcalc.com, useful for keeping these figures consistent.
Cross-Referencing Listings Across a Supplier’s Catalog
A pattern worth checking before treating any single accreditation claim as reliable: whether the same supplier documents its other listings with the same consistency. A tesamorelin listing with a strong, verifiable COA sitting next to other product listings that show none is a useful signal about how the supplier treats documentation generally, and it is one of the checks worth running before comparing supplier practices further, as covered on peer tesamorelin listing catalogs.
Longer-term human research data on GHRH analog use, including findings on sustained safety over extended treatment periods, further underscores why batch-level characterization matters for any material entering a research setting (see long-term safety findings for tesamorelin in HIV-associated abdominal fat accumulation). The standards reflected in that published research — named methods, defined criteria, and traceable batch records — are the same standards a legible COA is meant to demonstrate at the listing level.
Summary
Accreditation and certification claims on a tesamorelin listing fall into distinct categories: batch-specific certificates of analysis, facility-level quality designations like ISO or GMP, and unverified “third-party tested” statements. A COA verifies identity and purity for one lot; a facility badge verifies process controls, not product content; and a testing claim with no named lab or attached report verifies nothing on its own. Reading a listing’s documentation field by field, and checking whether that same rigor extends across a supplier’s full catalog, is a more reliable approach than treating any single badge or phrase as sufficient on its own.